the aid library

LIST OPTIONS

Filter

455

Sort by:

Direction:

Download (132)

View PDF (193)

Communities at the Centre

UNAIDS (2019) C2

Defending Rights Breaking Barriers Reaching People with HIV Services Global Aids Update 2019

Download (475)

View PDF (668)

Frequently asked questions on migration and health

World Health Organization, Regional Office for Europe (2015) CC

What are the common health problems of refugees and migrants arriving in the European Region?

Download (163)

View PDF (303)

European Drug Report 2019: trends and developments.

European Monitoring Centre for Drugs and Drug Addiction European Union (2019) C1

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug ... more

Download (234)

View PDF (239)

Health of refugees and migrants. WHO Region Europe 2018

World Health Organization WHO, Regional Office for Europe (2018) C_WHO

Regional situation analysis, practices, experiences, lessons learned and ways forward.

Download (521)

View PDF (709)

Evaluation of Protection in Humanitarian Action

Christoplos, I. and Dillon, N. with Bonino, F. ALNAP (2018) CC

This companion to the ALNAP EHA Guide offers protection-specific insights for evaluators and evaluation commissioners across the humanitarian sector. It covers the planning, data management and analysis phases of evaluation and addresses a range of challenges that – whilst not all unique to protec... more

Download (282)

View PDF (1514)

Migration and health: key issues

World Health Organization WHO, Regional Office for Europe (2016) C_WHO

The most frequent health problems of newly arrived refugees and migrants include accidental injuries, hypothermia, burns, gastrointestinal illnesses, cardiovascular events, pregnancy- and delivery-related complications, diabetes and hypertension. Female refugees and migrants frequently face specific... more

Download (333)

View PDF (649)

Refugee/Migrant crisis in Europe: Scenarios

MapAction; Assessement Capacities Projekt; Start Network (2016) C1

Possible developments in transit countries over the next 6 months, 24 March 2016

Download (427)

View PDF (871)

Cholera in Yemen: A case study of epidemic preparedness and response

The Johns Hopkins Center for Humanitarian Healt (2018) C1

The report offers 20 top recommendations for getting ahead of future outbreaks in Yemen and similarly complex humanitarian settings. In 2015, Yemen was declared a Level 3 emergency by the UN, kicking into gear the highest level of humanitarian support. A massive cholera outbreak followed, leading t... more

Download (224)

View PDF (333)

COMPENDIUM of health system responses to large-scale migration in the WHO European Region
recommended

World Health Organization WHO, Regional Office for Europe (2018) C_WHO

The scale of international migration in the WHO European Region has increased substantially in the last decade. The dynamics of large-scale migration pose specific challenges and opportunities to health systems, and responses will differ from country to country. Strengthening health system responses... more

Download (229)

View PDF (609)

Sudan: Multi-Year Humanitarian Strategy 2017-2019

UN Office for the Coordination of Humanitarian Affairs (2017) C1

Download (535)

View PDF (649)

Brighter futures: Protecting early brain development through salt iodization

United Nations Children’s Fund (UNICEF), Global Alliance for Improved Nutrition (GAIN) (2018)

The UNICEF-GAIN Partnership Project
The report notes that iodine deficiency is a leading cause of preventable brain damage worldwide. Insufficient iodine during pregnancy and infancy results in neurological and psychological deficits, reducing a child’s IQ by 8 to 10 points. This translates ... more

Download (384)

View PDF (590)

Philippines: Disaster Management Reference Handbook

Center for Excellence in Disaster Management and Humanitarian Assistance (2018) C1

The Philippine Government, International Non-government Organizations (INGOs) and local NGOs are all making attempts to address the impact of disasters and climate change at various levels. The Philippine Government has made significant strides in the implementation of disaster risk reduction (DRR) ... more

Download (211)

View PDF (342)

Landmine Monitor 2017

International Campaign to Ban Landmines – Cluster Munition Coalition (ICBL-CMC) (2017) C3

This is the 19th annual Landmine Monitor report. It is the sister publication to the Cluster Munition Monitor report, first published in November 2010. Landmine Monitor 2016 provides a global overview of the landmine situation. Chapters on developments in specific countries and other areas are ava... more

Download (160)

View PDF (310)

Disability Inclusion: Translating Policy into Practice in Humanitarian Action

Women's Refugee Commission (WRC) and UNICEF Lebanon (2014) CC

The report provides lessons and recommendations for other organizations and the wider humanitarian community on engaging persons with disabilities at all levels of humanitarian work. It draws on consultations with over 700 displaced persons—including persons with disabilities, their families, and ... more

Download (400)

View PDF (963)

Too young to wed

Save the Children (2014)

The growing problem of child marriage among Syrian girls in Jordan

Download (691)

View PDF (1593)

Rapid assessment of Ebola impact on reproductive health services and service seeking behaviour in Sierra Leone

Government of Sierra Leone, Department for International Development, UN Population Fund, Irish Aid (2015)

Download (194)

View PDF (173)

How to use social media to better engage people affected by crises

UN Office for the Coordination of Humanitarian Affairs (OCHA); ICRC (2020) C1

A brief guide for those using social media in humanitarian organizations

Download (94)

View PDF (138)

Global Humanitarian Response Plan COVID-19 Progress Report: Final Progress Report 22 February 2021

Office for the Coordination of Humanitarian Affairs OCHA (2021) C1

2020 was a year like no other. Amidst on-going humanitarian crises, largely fuelled by conflict and violence but also driven by the effects of climate change – such as the largest locust infestation in a generation – the world had to contend with a global pandemic. In less than one year (March-D... more

Download (111)

View PDF (130)

Financing Global Health 2017: Funding Universal Health Coverage and the Unfinished HIV/AIDS Agenda

Institute for Health Metrics and Evaluation (IHME) Institute for Health Metrics and Evaluation (IHME) (2018) C2

In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass... more

Download (237)

View PDF (321)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

COMPENDIUM of health system responses to large-scale migration in the WHO European Region recommended

COMPENDIUM of health system responses to large-scale migration in the WHO European Region
recommended